Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

XGN

Exagen Inc

Nov 27 • 04:00PM ET

1.58

Dollar change +0.02
Percentage change 1.28	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.86	Insider Own	49.17%	Shs Outstand	16.55M	Perf Week	0.52%
Market Cap	26.94M	Forward P/E	-	EPS next Y	-1.37	Insider Trans	-0.40%	Shs Float	8.66M	Perf Month	1.28%
Income	-32.47M	PEG	-	EPS next Q	-0.44	Inst Own	40.40%	Short Float / Ratio	0.08% / 0.51	Perf Quarter	-36.80%
Sales	51.62M	P/S	0.52	EPS this Y	46.56%	Inst Trans	-0.87%	Short Interest	0.01M	Perf Half Y	-49.03%
Book/sh	1.62	P/B	0.97	EPS next Y	7.17%	ROA	-39.96%	Target Price	5.75	Perf Year	-53.53%
Cash/sh	1.67	P/C	0.95	EPS next 5Y	-	ROE	-77.60%	52W Range	1.33 - 3.92	Perf YTD	-34.17%
Dividend	-	P/FCF	-	EPS past 5Y	-0.37%	ROI	-64.52%	52W High	-59.73%	Beta	1.12
Dividend %	-	Quick Ratio	4.61	Sales past 5Y	11.77%	Gross Margin	53.93%	52W Low	18.80%	ATR	0.17
Employees	204	Current Ratio	4.83	Sales Q/Q	-8.90%	Oper. Margin	-51.68%	RSI (14)	44.27	Volatility	9.01% 10.23%
Optionable	Yes	Debt/Eq	0.90	EPS Q/Q	35.42%	Profit Margin	-62.90%	Rel Volume	20.01	Prev Close	1.56
Shortable	Yes	LT Debt/Eq	0.83	Earnings	Nov 13 AMC	Payout	-	Avg Volume	14.05K	Price	1.58
Recom	1.33	SMA20	-1.03%	SMA50	-16.01%	SMA200	-35.82%	Volume	281,071	Change	1.28%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-05-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Oct-15-21	Resumed	Cowen	Outperform	$26
Apr-15-21	Initiated	Canaccord Genuity	Buy	$25
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight	$32
Oct-08-20	Initiated	BTIG Research	Buy	$18
Jun-02-20	Resumed	Cantor Fitzgerald	Overweight	$19 → $20
Oct-14-19	Initiated	William Blair	Outperform
Oct-14-19	Initiated	Cowen	Outperform	$17
Oct-14-19	Initiated	Cantor Fitzgerald	Overweight	$18

Nov-13-23 04:05PM	Exagen Inc. Reports Strong Third Quarter 2023 Results (GlobeNewswire)
Nov-09-23 04:05PM	Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers (GlobeNewswire) -6.25%
Nov-02-23 04:05PM	Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
Oct-30-23 04:05PM	Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023 (GlobeNewswire) +6.75%
Sep-28-23 04:05PM	Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting (GlobeNewswire)
04:05PM	Loading…
Sep-12-23 04:05PM	Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference (GlobeNewswire)
Aug-09-23 10:47AM	Exagen Inc. (NASDAQ:XGN) Q2 2023 Earnings Call Transcript (Insider Monkey) -7.22%
Aug-08-23 04:13AM	Q2 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 09:15AM	Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +8.76%
08:00AM	Exagen Inc. Reports Strong Second Quarter 2023 Results (GlobeNewswire)
Jul-26-23 04:05PM	Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference (GlobeNewswire)
Jul-25-23 04:05PM	Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023 (GlobeNewswire) -6.51%
Jul-24-23 04:05PM	Exagen Inc. Appoints Paul Kim to Board of Directors (GlobeNewswire)
07:33AM	This Exagen Insider Increased Their Holding In The Last Year (Simply Wall St.)
Jun-13-23 08:19AM	Exagen Inc.'s (NASDAQ:XGN) Low P/S No Reason For Excitement (Simply Wall St.) -8.36%
09:00AM	Loading…
May-30-23 09:00AM	Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference (GlobeNewswire)
May-17-23 07:11AM	Exagen (NASDAQ:XGN) shareholders are up 20% this past week, but still in the red over the last three years (Simply Wall St.) -6.90%
May-16-23 11:03AM	Q1 2023 Exagen Inc Earnings Call (Thomson Reuters StreetEvents) +19.51%
May-15-23 05:55PM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Exagen Inc. Reports First Quarter 2023 Results (GlobeNewswire)
May-01-23 04:05PM	Exagen Announces Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-24-23 04:05PM	Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023 (GlobeNewswire)
Mar-24-23 08:16AM	Exagen Inc. (NASDAQ:XGN) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 06:12AM	Exagen Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
Mar-21-23 07:40AM	Q4 2022 Exagen Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-23 05:25PM	Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results (GlobeNewswire)
Mar-06-23 04:05PM	Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023 (GlobeNewswire) +5.31%
Feb-27-23 09:00AM	Exagen Inc. to Participate in Upcoming March Conferences (GlobeNewswire)
Feb-14-23 06:19AM	Exagen Inc. (NASDAQ:XGN) insider upped their holding earlier this year (Simply Wall St.)
04:05PM	Loading…
Jan-30-23 04:05PM	Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-23-23 09:00AM	Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors (GlobeNewswire)
Nov-14-22 07:55PM	Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.49%
04:05PM	Exagen Inc. Reports Third Quarter 2022 Results (GlobeNewswire)
Nov-08-22 04:05PM	Exagen Inc. to Participate in Fourth Quarter Investor Conferences (GlobeNewswire)
Oct-31-22 04:05PM	Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022 (GlobeNewswire)
Oct-17-22 09:00AM	Exagen Announces Appointment of John Aballi as CEO (GlobeNewswire)
Oct-04-22 08:25AM	Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer (GlobeNewswire)
Sep-20-22 04:05PM	Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting (GlobeNewswire)
Sep-19-22 10:20AM	The past three years for Exagen (NASDAQ:XGN) investors has not been profitable (Simply Wall St.) -8.67%
Sep-01-22 04:05PM	Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients (GlobeNewswire)
Aug-05-22 12:00PM	Exagen Inc. (XGN) Q2 2022 Earnings Call Transcript (Motley Fool) -23.61%
Aug-04-22 06:55PM	Exagen Inc. (XGN) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:06PM	Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA (GlobeNewswire)
04:05PM	Exagen Inc. Reports Second Quarter 2022 Results (GlobeNewswire)
Jul-25-22 04:05PM	Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference (GlobeNewswire) +8.23%
Jul-21-22 04:05PM	Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022 (GlobeNewswire)
Jul-05-22 08:25AM	Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility (GlobeNewswire)
Jun-21-22 08:10AM	Does Exagen (NASDAQ:XGN) Have A Healthy Balance Sheet? (Simply Wall St.) +8.65%
Jun-09-22 08:25AM	Exagen Inc. Expands Coverage with MediNcrease (GlobeNewswire) +10.78%
May-26-22 04:05PM	Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference (GlobeNewswire) +9.50%
May-16-22 04:05PM	Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus (GlobeNewswire)
May-11-22 05:55PM	Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -16.16%
04:06PM	Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test (GlobeNewswire)
04:05PM	Exagen Inc. Reports First Quarter 2022 Results (GlobeNewswire)
May-10-22 10:45AM	AdaptHealth Corp. (AHCO) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +10.25%
May-03-22 05:15PM	MacroGenics (MGNX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-01-22 12:00PM	Exagen Announces Five-Week Campaign for Lupus Awareness Month (GlobeNewswire)
Apr-25-22 04:05PM	Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022 (GlobeNewswire)
Apr-20-22 04:05PM	Exagen Inc. to Participate in Investor Summit Groups Q2 Conference (GlobeNewswire)
Apr-12-22 07:22AM	Shareholders in Exagen (NASDAQ:XGN) have lost 61%, as stock drops 15% this past week (Simply Wall St.)
Mar-30-22 08:25AM	Exagen Inc. Expands In-Network Access with Evolutions Healthcare Systems (GlobeNewswire)
Mar-22-22 10:00PM	Exagen Inc. (XGN) Q4 2021 Earnings Call Transcript (Motley Fool)
05:25PM	Exagen Inc. (XGN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Exagen Inc. Expands In-Network Benefit with Additional 22.7 Million Lives (GlobeNewswire)
04:05PM	Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results (GlobeNewswire)
Mar-16-22 04:05PM	Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board (GlobeNewswire) +6.52%
Mar-09-22 05:35PM	Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +13.31%
04:05PM	Exagen Inc. to Participate in the 2022 KeyBanc Capital Markets Life Sciences and MedTech Investor Forum (GlobeNewswire)
Mar-08-22 04:05PM	Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022 (GlobeNewswire)
Mar-07-22 08:05AM	Eagle Pharmaceuticals (EGRX) Lags Q4 Earnings and Revenue Estimates (Zacks)
Feb-24-22 05:40PM	MacroGenics (MGNX) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
Feb-08-22 02:38PM	Samjo Capital LLC Buys RumbleON Inc, Iteris Inc, Thryv Holdings Inc, Sells GAN, Exagen Inc, ... (GuruFocus.com)
Feb-02-22 04:05PM	Exagen Inc. to Participate in the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire) -7.49%
Jan-12-22 10:46AM	Health Check: How Prudently Does Exagen (NASDAQ:XGN) Use Debt? (Simply Wall St.)
Jan-09-22 12:00PM	Exagen Inc. and Queen Mary University of London Announce Exclusive License and Collaboration to Develop Novel Patented Molecular Signatures for Rheumatoid Arthritis Biologic Therapeutic Selection (GlobeNewswire)
Nov-17-21 04:05PM	Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference (GlobeNewswire)
Nov-11-21 08:30AM	Exagen Inc. (XGN) Q3 2021 Earnings Call Transcript (Motley Fool) +6.21%
Nov-10-21 05:55PM	Exagen Inc. (XGN) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +8.02%
04:05PM	Exagen Inc. Reports Third Quarter 2021 Results (GlobeNewswire)
Nov-04-21 04:05PM	Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum (GlobeNewswire)
Nov-03-21 03:01PM	Earnings Preview: Exagen Inc. (XGN) Q3 Earnings Expected to Decline (Zacks)
Oct-27-21 04:05PM	Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021 (GlobeNewswire)
08:25AM	Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus (GlobeNewswire)
Oct-25-21 08:25AM	Exagen Inc. Announces $27.2 Million Debt Refinancing (GlobeNewswire)
Oct-21-21 04:05PM	Exagen Showcases Eight Scientific Presentations at ACRs Virtual Annual Meeting in November 2021 (GlobeNewswire)
Oct-13-21 11:05AM	The past year for Exagen (NASDAQ:XGN) investors has not been profitable (Simply Wall St.)
Sep-13-21 04:15PM	Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
Aug-10-21 07:01AM	Exagen Inc. (XGN) Q2 2021 Earnings Call Transcript (Motley Fool) +24.59%
Aug-09-21 06:35PM	Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Exagen Inc. Reports Second Quarter 2021 Results (GlobeNewswire)
Jul-30-21 08:25AM	Exagen Appoints Ana Hooker to Board of Directors (GlobeNewswire)
Jul-29-21 08:25AM	Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference (GlobeNewswire)
Jul-26-21 04:06PM	Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021 (GlobeNewswire)
Jul-20-21 03:02PM	Earnings Preview: Exagen Inc. (XGN) Q2 Earnings Expected to Decline (Zacks)
Jul-15-21 07:04AM	Is Exagen (NASDAQ:XGN) Using Too Much Debt? (Simply Wall St.)
Jul-13-21 04:05PM	AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions (GlobeNewswire)
Jun-22-21 09:25AM	WorkWave launches as standalone portfolio company following separation from IFS and announces transformational add-ons (PR Newswire)
Jun-18-21 08:29AM	Exagen Elects Frank Stokes to Board of Directors (GlobeNewswire)
May-24-21 04:05PM	Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference (GlobeNewswire) -5.32%

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ABALLI JOHN	President and CEO	Oct 17	Sale	1.75	33,819	59,018	415,984	Oct 18 04:05 PM
TULLIS JAMES L L	10% Owner	Jun 15	Buy	3.11	167	519	1,515,839	Jun 20 05:04 PM
Adawi Kamal	CFO and Corporate Secretary	Mar 02	Sale	2.30	3,667	8,432	188,271	Mar 03 04:38 PM
Hazeltine Mark	Chief Business Officer	Feb 08	Sale	2.69	5,821	15,672	93,872	Feb 10 04:08 PM
Adawi Kamal	CFO and Corporate Secretary	Feb 08	Sale	2.69	5,821	15,671	91,938	Feb 10 04:05 PM
ABALLI JOHN	President and CEO	Dec 08	Buy	2.68	90,000	241,200	440,000	Dec 09 09:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

XGN

Exagen Inc

Upgrade your FINVIZ experience